These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 15914875)
1. Daptomycin: a novel cyclic lipopeptide antimicrobial. Schriever CA; Fernández C; Rodvold KA; Danziger LH Am J Health Syst Pharm; 2005 Jun; 62(11):1145-58. PubMed ID: 15914875 [TBL] [Abstract][Full Text] [Related]
2. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. Steenbergen JN; Alder J; Thorne GM; Tally FP J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644 [TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Rybak MJ Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721 [TBL] [Abstract][Full Text] [Related]
4. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Carpenter CF; Chambers HF Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832 [TBL] [Abstract][Full Text] [Related]
8. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Kanafani ZA; Corey GR Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin: a review 4 years after first approval. Sauermann R; Rothenburger M; Graninger W; Joukhadar C Pharmacology; 2008; 81(2):79-91. PubMed ID: 17940348 [TBL] [Abstract][Full Text] [Related]
10. [Daptomycin, the first cydal antibiotic of a new class active against Gram positive pathogens]. Stefani S; Esposito S Infez Med; 2006 Dec; 14(4):179-96. PubMed ID: 17380085 [TBL] [Abstract][Full Text] [Related]
12. Daptomycin: a new drug class for the treatment of Gram-positive infections. Alder JD Drugs Today (Barc); 2005 Feb; 41(2):81-90. PubMed ID: 15821781 [TBL] [Abstract][Full Text] [Related]
13. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Hair PI; Keam SJ Drugs; 2007; 67(10):1483-512. PubMed ID: 17600394 [TBL] [Abstract][Full Text] [Related]
14. Update on daptomycin: the first approved lipopeptide antibiotic. Lee SY; Fan HW; Kuti JL; Nicolau DP Expert Opin Pharmacother; 2006 Jul; 7(10):1381-97. PubMed ID: 16805723 [TBL] [Abstract][Full Text] [Related]
16. Daptomycin: a comparison of two intravenous formulations. Frankenfeld C; Mittal S; Melendez Y; Mendez-Vigo L; Lamp KC; Keller KN; Bertolami SR Drug Des Devel Ther; 2018; 12():1953-1958. PubMed ID: 29988771 [TBL] [Abstract][Full Text] [Related]
17. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias]. Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024 [TBL] [Abstract][Full Text] [Related]
19. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient]. Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665 [TBL] [Abstract][Full Text] [Related]
20. Daptomycin: a review of properties, clinical use, drug delivery and resistance. Vilhena C; Bettencourt A Mini Rev Med Chem; 2012 Mar; 12(3):202-9. PubMed ID: 22356191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]